Trial of the effect of food ingredients on mobility and muscle strength

Trial of the effect of food ingredients on mobility and muscle strength - Trial of the effect of food ingredients on mobility and muscle strength

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024605

Enrollment

110

Registered

2018-06-30

Start date

2016-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Supplement containing food ingredients such as glucosamine, 16 Weeks Supplement not containing food ingredients such as glucosamine, 16 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Women and men aged 40 to 74 years at the time of acquisition of agreement in participating in this study 2) Presence of knee pain 3) Person who begins declining in mobility 4) Person who can come to the medical organization for the measurement at the date of visiting 5) Person who can understand the purpose and content of this study and agree in writing to participate in this study

Exclusion criteria

Exclusion criteria: 1) Kellgren-Lawrence grades II-IV 2) Presence of hyperuricemia 3) Presence of rheumatoid arthritis that may cause joint pain 4) Surgical treatment of knee joint(s) needed or undergone 5) Need for pharmacological articular treatments during the study period 6) Presence of disease in locomotor organs affecting the efficacy assessment of this study 7) Presence of history of osseous or articular diseases other than OA within the past 3 months 8) Use of product affecting the data of this study, such as medicine, food for specified health use, supplement, diet food 9) Daily use of a cane or a supporter 10) Daily use of hot spa or massage therapy 11) Daily or occasional vigorous exercise 12) Female in pregnancy, lactation and scheduled pregnancy period 13) With previous and present serious disease such as liver disorder, kidney disorder, cardiac affection, lung disorder, digestive disorder, organ disorder, diabetes mellitus, food allergy 14) Investigator's judgment for other reason

Design outcomes

Primary

Measure	Time frame
The stage of the locomotive syndrome risk based on three indices for assessing risk of locomotive syndrome at 8th week, 12th week and 16th week of intake	—

Secondary

Measure	Time frame
Measured value of three indices for assessing risk of locomotive syndrome at 8th week, 12th week and 16th week of intake	—

Countries

Japan

Contacts

Public ContactNoriyuki Kanzaki

Suntory Wellness Limited Institute for Health Care Science

Noriyuki_Kanzaki@suntory.co.jp050-3182-0666

Outcome results